Christine D. Berg

13.1k total citations · 2 hit papers
43 papers, 2.5k citations indexed

About

Christine D. Berg is a scholar working on Oncology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Christine D. Berg has authored 43 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 12 papers in Reproductive Medicine and 12 papers in Cancer Research. Recurrent topics in Christine D. Berg's work include Colorectal Cancer Screening and Detection (12 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cancer Risks and Factors (6 papers). Christine D. Berg is often cited by papers focused on Colorectal Cancer Screening and Detection (12 papers), Ovarian cancer diagnosis and treatment (12 papers) and Cancer Risks and Factors (6 papers). Christine D. Berg collaborates with scholars based in United States, United Kingdom and Canada. Christine D. Berg's co-authors include Amy Berrington de González, Brenda K. Edwards, Nadia Howlader, Peter M. Ravdin, Donald A. Berry, Kathleen A. Cronin, Rowan T. Chlebowski, Eric J. Feuer, Elaine Ron and Ethel S. Gilbert and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Christine D. Berg

43 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Decrease in Breast-Cancer Incidence in 2003 in the United States

2007 682 citations Peter M. Ravdin, Kathleen A. Cronin et al. New England Journal of Medicine profile →
Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries

2011 351 citations Amy Berrington de González, Rochelle E. Curtis et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine D. Berg United States	18	1.2k	768	727	422	390	43	2.5k
Laura Cortesi Italy	28	1.0k 0.9×	712 0.9×	885 1.2×	753 1.8×	343 0.9×	172	2.9k
M. Bontenbal Netherlands	31	2.1k 1.8×	1.2k 1.5×	667 0.9×	575 1.4×	480 1.2×	66	3.4k
Indraneel Mittra India	26	1.3k 1.1×	872 1.1×	296 0.4×	457 1.1×	338 0.9×	84	2.6k
Caroline Lohrisch Canada	23	1.3k 1.1×	934 1.2×	410 0.6×	296 0.7×	408 1.0×	80	2.1k
Javaid Iqbal Canada	15	1.1k 0.9×	782 1.0×	430 0.6×	286 0.7×	206 0.5×	23	1.8k
Reena S. Cecchini United States	20	1.8k 1.5×	959 1.2×	1.1k 1.4×	393 0.9×	422 1.1×	49	2.9k
Jonine L. Bernstein United States	33	1.1k 1.0×	1.4k 1.8×	1.4k 1.9×	875 2.1×	574 1.5×	138	3.7k
Rossella Lauria Italy	18	1.2k 1.0×	683 0.9×	352 0.5×	416 1.0×	279 0.7×	61	1.9k
Marc Thill Germany	22	1.1k 0.9×	889 1.2×	247 0.3×	253 0.6×	507 1.3×	163	2.3k
Adnan Ghafoor United States	2	1.5k 1.2×	512 0.7×	316 0.4×	891 2.1×	907 2.3×	3	3.2k

Countries citing papers authored by Christine D. Berg

Since Specialization

Citations

This map shows the geographic impact of Christine D. Berg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine D. Berg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine D. Berg more than expected).

Fields of papers citing papers by Christine D. Berg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine D. Berg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine D. Berg. The network helps show where Christine D. Berg may publish in the future.

Co-authorship network of co-authors of Christine D. Berg

This figure shows the co-authorship network connecting the top 25 collaborators of Christine D. Berg. A scholar is included among the top collaborators of Christine D. Berg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine D. Berg. Christine D. Berg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Berg, Christine D., Philip E. Castle, David L. Crosby, et al.. (2024). Considerations for using potential surrogate endpoints in cancer screening trials. The Lancet Oncology. 25(5). e183–e192. 15 indexed citations

Manning, Brendan D., Laura Bortolin, Emily S. Winn-Deen, et al.. (2024). Evaluation of a novel extracellular vesicle (EV) based ovarian cancer (OC) screening test in asymptomatic postmenopausal women.. Journal of Clinical Oncology. 42(16_suppl). 5553–5553. 1 indexed citations

Hackshaw, Allan & Christine D. Berg. (2021). An efficient randomised trial design for multi-cancer screening blood tests: nested enhanced mortality outcomes of screening trial. The Lancet Oncology. 22(10). 1360–1362. 15 indexed citations

Prorok, Philip C., Patrick Wright, Thomas Riley, et al.. (2018). Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial. Reviews on Recent Clinical Trials. 13(4). 257–273. 6 indexed citations

Zhu, Claire S., Paul F. Pinsky, James E. Moler, et al.. (2017). Data sharing in clinical trials: An experience with two large cancer screening trials. PLoS Medicine. 14(5). e1002304–e1002304. 6 indexed citations

Temkin, Sarah M., Eric A. Miller, Goli Samimi, et al.. (2017). Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival. European Journal of Cancer. 87. 182–188. 15 indexed citations

Pinsky, Paul F., Kelly J. Yu, Barnett S. Kramer, et al.. (2016). Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up. Gynecologic Oncology. 143(2). 270–275. 101 indexed citations

Deppen, Stephen A., Melinda C. Aldrich, Patricia Hartge, et al.. (2012). Cancer Screening: The Journey from Epidemiology to Policy. Annals of Epidemiology. 22(6). 439–445. 10 indexed citations

González, Amy Berrington de, Kwang Pyo Kim, Amy B. Knudsen, et al.. (2011). Radiation-Related Cancer Risks From CT Colonography Screening: A Risk-Benefit Analysis. American Journal of Roentgenology. 196(4). 816–823. 83 indexed citations

10.

González, Amy Berrington de, Rochelle E. Curtis, Stephen F. Kry, et al.. (2011). Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. The Lancet Oncology. 12(4). 353–360. 351 indexed citations breakdown →

11.

Urban, Nicole, Jason D. Thorpe, Lindsay Bergan, et al.. (2011). Potential Role of HE4 in Multimodal Screening for Epithelial Ovarian Cancer. JNCI Journal of the National Cancer Institute. 103(21). 1630–1634. 40 indexed citations

12.

Izmirlian, Grant, Robert L. Grubb, Amanda Black, et al.. (2009). PRE-BIOPSY PROSTATE CANCER NOMOGRAMS BASED UPON SERIAL PSA SCREENING DATA IN THE PLCO TRIAL WITH VERIFICATION BIAS CORRECTION. The Journal of Urology. 181(4). 609–609. 1 indexed citations

13.

Grünhage, F, Matthias Jungck, Christine D. Berg, et al.. (2007). Association of familial colorectal cancer with variants in the E-cadherin (CDH1) and cyclin D1 (CCND1) genes. International Journal of Colorectal Disease. 23(2). 147–154. 53 indexed citations

14.

Ravdin, Peter M., Kathleen A. Cronin, Nadia Howlader, et al.. (2007). The Decrease in Breast-Cancer Incidence in 2003 in the United States. New England Journal of Medicine. 356(16). 1670–1674. 682 indexed citations breakdown →

15.

Hayes, Richard B., Alice J. Sigurdson, Lee E. Moore, et al.. (2005). Methods for etiologic and early marker investigations in the PLCO trial. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 592(1-2). 147–154. 104 indexed citations

16.

Gagnon, Gregory J., K. William Harter, Christine D. Berg, et al.. (2000). Limitations of reduced-field irradiated volume and technique in conventional radiation therapy of prostate cancer:Implications for conformal 3-D treatment. International Journal of Cancer. 90(5). 265–274. 2 indexed citations

17.

Swain, Sandra M., Julia H. Rowland, Kevin P. Weinfurt, et al.. (1996). Intensive outpatient adjuvant therapy for breast cancer: results of dose escalation and quality of life.. Journal of Clinical Oncology. 14(5). 1565–1572. 36 indexed citations

18.

Bergtold, David S., Christine D. Berg, & Michael G. Simic. (1990). Urinary Biomarkers in Radiation Therapy of Cancer. Advances in experimental medicine and biology. 264. 311–316. 17 indexed citations

19.

Berg, Christine D., et al.. (1986). The combined use of interferon and radiotherapy in cancer management.. PubMed. 13(3 Suppl 2). 78–83. 25 indexed citations

20.

Berg, Christine D., Hajime Nawata, Diane Bronzert, & Marc E. Lippman. (1983). 1 Altered estrogen and antiestrogen responsivity in clonai, variants of MCF-7 human breast cancer cells. Journal of Steroid Biochemistry. 19. 1–1. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact